Molecular Reagent Xpert® Methicillin-Resistant Staphylococcus Aureus (MRSA) NxG 10 Tests

Features

• Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients
• Approximately 171,200 healthcare-associated MRSA infections are acquired annually in the European Union (EU), resulting in 5,400 attributable deaths, more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs
• Between 2 and 53 million people are estimated to carry MRSA worldwide
• The average length of stay (LOS) for all MRSA patients in the EU is 11.5 days with an average attributable cost of € 7,478 per patient

More Information

• SDS